- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03495518
Enabling Symptom Identification and Tracking in Children Receiving Cancer Treatment
Refinement and Early Evaluation of SPARK, an Approach to Enable Symptom Screening and Monitoring by Children Receiving Cancer Treatments
Children with cancer and hematopoietic stem cell transplant (HSCT) recipients suffer from severe and bothersome symptoms because treatments are intense. So, the investigators developed SPARK (Supportive care Prioritization, Assessment and Recommendations for Kids), a website devoted to helping children track symptoms and providing a way to let doctors and nurses know which symptoms are bothersome. This study will examine the likelihood that children will complete SPARK once daily, help the investigators figure out how to improve the website so that children will use it, and help the investigators plan the large scale trial to test its efficacy in improving quality of life (QoL).
Participants will be children with cancer or HSCT recipients who are 8-18 years of age and who are expected to be in hospital or in clinic daily for 5 days.To determine the feasibility of a randomized controlled trial (RCT) of symptom feedback to healthcare providers
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Methods: Participants will be children with cancer or HSCT recipients who are 8-18 years of age and who can understand English, and who are expected to be in hospital or in clinic daily for 5 days.
SPARK RCT will be a pilot multi-center RCT in which we will randomize children to either undergo daily symptom screening for 5 days with symptom reports provided to the healthcare team or standard of care. Feasibility will be met if at least 30 participants are enrolled within one year and at least 75% complete at least 60% of evaluations.
Quality of the Idea Children receiving cancer treatment have excellent survival outcomes, in part, related to the provision of intensive therapies. Unfortunately, most children suffer and experience severe and bothersome treatment-related symptoms. Symptoms not only impact on QoL and morbidity but, in addition, may negatively influence future psychosocial functioning.
Symptoms remain unaddressed even during healthcare encounters because children do not complain and clinicians fail to ask about them. We recently developed SSPedi, a pediatric-specific symptom screening tool on an iPad. SSPedi, however, consists only of the questions which ask about symptoms. SPARK is the web-based application which will facilitate access to SSPedi, encourage symptom screening, generate reports and allow children to track their symptoms. Careful thought to design is required to ensure SPARK optimizes future use and has clinical utility. The proposed project output is a product that facilitates longitudinal symptom screening and provides the groundwork for a future RCT of symptom feedback.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- The Hospital For SickKids
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- We will include children with cancer and HSCT recipients who are 8-18 years of age at enrollment and who can understand English.
- Participants may be inpatients or outpatients, and may be actively receiving cancer treatment or may have completed treatment.
Exclusion Criteria:
- Exclusion criteria will be illness severity, cognitive disability, or visual impairment that precludes utilization of SPARK according to the healthcare team.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Symptom feedback to Health Care Provider
For those randomized to the intervention arm, symptom screening using SPARK will be completed once daily for 5 days on an iPad using the approach refined in aim 2. Daily SSPedi reports will be printed and provided in the patient chart.
On days 1 and 3±1, a report describing symptoms that are "a lot" or "extremely" bothersome will be emailed to the physician providing direct medical care
|
These children will complete SPARK daily for 5 days in a row, daily symptom reports will be printed and provided in the patient chart.
On days 1 and 3, a report describing symptoms that are "a lot" or "extremely" bothersome will be emailed to the physician providing direct medical
|
ACTIVE_COMPARATOR: Standard of care
For those randomized to the control arm, a clinical research associate will visit the participant on days 1 and 5±1 and will obtain SSPedi scores on an iPad.
Reports will not be printed or emailed to the physician.
|
A clinical research associate will visit the participant on days 1 and 5±1 and will obtain SSPedi scores on an iPad.
Reports will not be printed or emailed to the physician.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of an RCT of symptom feedback to healthcare providers versus standard of care
Time Frame: Study will be enrolling for 1 year with a goal to enroll 30 participants. Feasibility will be determined once all 30 participants have completed the study after 1 year
|
Will be determined by both the number of patients who are recruited for this study, and the number of patients who complete at least 60% of evaluations.
We will aim to enroll 30 participants at SickKids over one year.
Outcome feasibility will be met if at least 30 participants are enrolled within one year and at least 75% complete at least 60% of evaluations
|
Study will be enrolling for 1 year with a goal to enroll 30 participants. Feasibility will be determined once all 30 participants have completed the study after 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pediatric Quality of Life (Peds QL) Cancer Module Acute Version
Time Frame: Measure will be completed by participant on day 5±1 day.
|
Measures self-reported symptoms related to cancer treatment, capturing physical, psychological and cognitive health. 5-point likert scale ranging from 0(almost never) to 4 (almost always); there is no weighting of items. Scores are transformed on a scale from 0 to 100. Items are reversed scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, 4=0. Mean score is calculated= Sum of the items over the number of items answered. Total Score is used and calculated by: Sum of all the items over the number of items answered on all the Scales. Higher scores indicate lower problems. |
Measure will be completed by participant on day 5±1 day.
|
Symptom Screening in Pediatrics (SSPedi)
Time Frame: Those randomized to the intervention arm measure will be completed by participant every day for 5 days. Those randomized to control arm measure will be completed by participant on Days 1 and 5±1 day.
|
Self-reported symptom screening questionnaire asking pediatric patients (age 8-18) how bothered they are by 15 identified symptoms and side effects of cancer treatment.
This 5-point Likert scale score from 0 (not bothered at all) to 4 (extremely bothered), and has a total score ranging from 0-60, with a higher number indicating more bother cancer-related symptoms.
Likert scores will be summed for a total score that ranges from 0 (none) to 60 (worst possible).
|
Those randomized to the intervention arm measure will be completed by participant every day for 5 days. Those randomized to control arm measure will be completed by participant on Days 1 and 5±1 day.
|
Faces Pain Scale Revised
Time Frame: Measure will be completed on day 5±1 day.
|
The Faces Pain Scale Revised is a self-report measure of pain intensity developed for children to score the sensation of pain on the 0-to-10 metric.
The scale shows a close linear relationship with visual analog pain scale, counting left to right; 0" = "no pain" and "10" = "very much pain
|
Measure will be completed on day 5±1 day.
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- REB #1000053137
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaRecruitingImprove Quality of LifeItaly
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
Clinical Trials on Symptom feedback to Health Care Provider
-
The Hospital for Sick ChildrenNational Cancer Institute (NCI)Recruiting
-
University of North Carolina, Chapel HillHarvard Pilgrim Health Care; Robert Wood Johnson FoundationCompleted
-
San Diego State UniversityCompletedType 2 Diabetes | Psychological Distress | Cardiovascular Risk Factors | Glycemic ControlUnited States
-
Providence Health & ServicesPatient-Centered Outcomes Research Institute; Oregon Health and Science University and other collaboratorsUnknown
-
US Department of Veterans AffairsCompletedOutcomes | Health Status Measures | Continuous Quality ImprovementUnited States
-
Dartmouth-Hitchcock Medical CenterNational Institute of Mental Health (NIMH)Enrolling by invitationHealth Anxiety | Illness Anxiety Disorder | Somatic Symptom DisorderUnited States
-
University of Alabama at BirminghamWithdrawnObesity | PreDiabetes | Type 2 DiabetesUnited States
-
Johns Hopkins UniversityPatient-Centered Outcomes Research Institute; National Heart, Lung, and Blood...CompletedUncontrolled HypertensionUnited States
-
University of DundeeUniversity of Strathclyde; Chief Scientist Office of the Scottish Government; Information Services Division, NHS ScotlandCompletedComplications of Surgical and Medical Care: General TermsUnited Kingdom
-
University of St AndrewsUniversity of ManchesterCompleted